01 2Boehringer Ingelheim Pharma GmbH and Co. KG
02 1Patheon Manufacturing Services LLC
01 1ALTEPLASE
02 2Alteplase
01 2Germany
02 1U.S.A
NDC Package Code : 12714-083
Start Marketing Date : 1987-11-13
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100mg/100mg)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 12714-082
Start Marketing Date : 1987-11-13
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50mg/50mg)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 63552-041
Start Marketing Date : 2001-09-04
End Marketing Date : 2024-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (2.2mg/2mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
We have 2 companies offering Alteplase
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
